Poland (PL)

Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on Ethylzingerone - 'Hydroxyethoxyphenyl Butanone' (HEPB) - Cosmetics Europe No P98-CAS No 569646-79-3-Submission II (eye irritation) (2019) Bernauer U, Bodin L, Chaudhry Q, Coenraads P, Dusinska M, Ezendam J, Gaffet E, et al. Journal article, Editorial Opinion of the Scientific Committee on consumer safety (SCCS) - Final opinion on the safety of fragrance ingredient Acetylated Vetiver Oil (AVO) - (Vetiveria zizanioides root extract acetylated) - Submission III (2019) Bernauer U, Bodin L, Chaudhry Q, Coenraads P, Dusinska M, Ezendam J, Gaffet E, et al. Journal article, Editorial Delay Between the Onset of Psoriasis and Arthritis in PsA Patients from the PsART International Cohort (2019) Tascilar K, Aydin SZ, Akar S, Aksu K, Bakirci S, Bayindir O, Can M, et al. Conference contribution ABSORB bioresorbable scaffold versus Xience metallic stent in acute coronary syndromes with treated with percutaneous coronary intervention. A subanalysis of the COMPARE-ABSORB trial (2019) Van Geuns RJ, Smits PC, Chang CC, Wlodarczyk A, Chevalier B, West N, Gori T, et al. Conference contribution Reduction in blood pressure following renal denervation for patients with differing baseline cardiovascular risk (2019) Mahfoud F, Mancia G, Schmieder R, Narkiewicz K, Ruilope L, Schlaich M, Williams B, et al. Conference contribution Baseline characteristics from CLARINET FORTE: Evaluating lanreotide autogel (LAN) 120mg every 14 days in patients with progressive pancreatic or midgut neuroendocrine tumours during a standard first-line LAN regimen (2019) Ruszniewski P, Cwikla J, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Thanh XMT, et al. Conference contribution Emergent de Sitter epoch of the loop quantum cosmos: A detailed analysis (2019) Assanioussi M, Dapor A, Liegener K, Pawlowski T Journal article Impact of Eligibility Criteria on Clinical Outcomes of Firehawk and XIENCE Coronary Drug-Eluting Stent in an All-Comers Randomized Trial (2019) Saito Y, Wijns W, Baumbach A, Xu B, Kelbaek H, Van Royen N, Zheng M, et al. Conference contribution Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial (2019) Chang CC, Onuma Y, Chevalier B, West N, Gori T, Barbato E, Tarantini G, et al. Conference contribution Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial): Very Late Device Thrombosis While on Extended DAPT (2019) Van Geuns RJ, Chang CC, Chevalier B, Gori T, Barbato E, Tarantini G, Achenbach S, et al. Conference contribution